peptides-frederick-md Peptide Logic LLC is a biopharmaceutical company focused on developing innovative peptide-based therapeutics.We are a clinical-stage biotechnology company revolutionizing the discovery and development process for novelpeptidetherapeutics for patients with serious ... The company leverages advanced technologies to create novel treatments, particularly in areas like pain management and the opioid crisis, with a goal of delivering transformative solutions for patients.
Peptide Logic LLC is actively involved in the development of peptide-antibody conjugates (PACs) and other engineered peptide therapeutics. Their work aims to address significant unmet medical needs, including the development of non-addictive pain relief options. The company's research extends to targets such as Somatostatin Receptor Type 4 (SSTR4) agonists, indicating a strategic approach to developing therapies for specific biological pathwaysMethod of administering a thymosin alpha 1 peptide.
The company's approach often involves combining the advantages of synthetic peptides with other biotechnological tools, such as recombinant antibodies. This integration allows for the creation of sophisticated therapeutic agents. While specific platform names like "eCAP" (engineered cationic antibiotic peptide) are associated with related entities like Peptilogics, the general principle of engineered peptide platforms is central to the innovation landscape in which Peptide Logic operates. Similarly, the broader field sees advancements like AI-driven drug discovery, exemplified by companies like Pepticom, underscoring the dynamic nature of peptide therapeutics development.LA‑SSTR4 agonists (Peptide Logic): a SSTR4 agonists Drug, Initially developed byPeptide Logic LLC, Now, its global highest R&D status is Preclinical, ...
Peptide Logic's drug candidates, such as LA-SSTR4 agonists and GPCR agonists, have reached the preclinical stage of research and development. This phase is crucial for evaluating the safety and efficacy of potential treatments before they advance to human clinical trialsPeptilogics is ushering in a new era of engineeredpeptidetherapeutics to restore mobility and hope for millions of people worldwide. Learn More .... The company has also received significant grant funding, including a $2.9 million SBIR Phase II grant, underscoring the recognition and potential of their therapeutic pipeline. Their work on neutralizing prolactin antibodies also highlights a diverse research portfolio.Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases.
Peptide Logic LLC is based in San Diego, CaliforniaPeptide Logic LLC| 3993 Via Cangrejo, San Diego, CA, 92121 |. The company operates with a lean structure, typically having fewer than 25 employees and an annual revenue under $5 million, as indicated by company profile data. This size often allows for agility and focus in specialized research areas. Their operational scope includes the development and production of custom peptides for research alongside their proprietary therapeutic development efforts.
It is important to distinguish Peptide Logic LLC from similarly named companies, such as "Peptilogics," which is also a clinical-stage biotechnology company focused on novel peptide therapeutics, particularly in areas like antibiotic development.LA‑SSTR4 agonists (Peptide Logic) - Drug Targets ... While both entities are in the peptide therapeutic space, their specific pipelines, platforms, and company histories may differ. "Logic Peptides" is another related entity, focusing on supplying high-purity, research-grade peptides to scientists. Understanding these distinctions is key when researching companies within the peptide therapeutics sector.
Join the newsletter to receive news, updates, new products and freebies in your inbox.